In a report named ” United States Pain Management Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2022-2030,” issued recently by Renub Research, market share insights are incorporated along with a detailed industry analysis. The analysis of competitors, topographical regions, and growth for United States pain management therapeutics market is also enclosed in the report.

Expert Insights: Ask Analyst or Download Full Report with TOC & Figures: https://www.renub.com/united-states-pain-management-therapeutics-market-p.php

United States pain management therapeutics market will grow at a CAGR of 3.65%, during 2022 and 2030. In recent years, there has been an increase in pain management therapeutics, because of the geriatric population in the United States. Furthermore, musculoskeletal conditions such as osteoarthritis, orthopaedic degenerative diseases, arthritis, and rheumatoid arthritis are on the rise. This has increased the prevalence of chronic pain in these people, as well as their inability to perform daily tasks. According to the Centers for Disease Prevalence and Control (CDC), over 58.5 million adults in the United States have arthritis. The CDC predicted that by 2040, approximately 35 million people would be limited in their usual activities due to arthritis. This has accelerated the market for pain management stimulators to control chronic pain.

Increased government spending on pain management treatments also drives market growth. Furthermore, various organizations, along with the government, fund pain management, is expected to contribute to market growth. For example, $250,000 is available to support and promote innovative, high-impact research for developing and managing chronic pain therapeutics, according to a recent article published in Congressionally Directed Medical Research Programs 2022.

Moreover, growth and innovations in the pharmaceutical industry for the production of pain-relieving drugs because of a large pool of health-conscious consumers create an opportunity for the U.S. pain management drug market. Boston Scientific Corporation obtained Baylis Medical Company, Inc. in February 2022. This acquisition expanded Boston Scientific’s electrophysiology product and structural heart portfolios, including the VersaCross Transseptal and radiofrequency NRG Platforms and dilators used to allow left heart access. So, United States Pain Management Therapeutics Market will value about US$33.71 billion by 2030.

Request a free sample copy of the report: https://www.renub.com/request-sample-page.php?gturl=united-states-pain-management-therapeutics-market-p.php

Pharmaceutical pain management therapeutics are experiencing growth in the United States.

The demand for effective pain relief solutions has led to the development of innovative medications and treatments addressing various types of pain. Moreover, regulatory support, heightened research efforts, and evolving healthcare policies have facilitated the introduction of novel therapies. As healthcare providers prioritize comprehensive pain management approaches, the pharmaceutical sector responds with advanced options, contributing to the expansion of pain management therapeutics in the United States.

Therapeutics – United States pain management therapeutics Market has been covered from 2 viewpoints.

1.    Pharmaceuticals

2.    Devices

With its potential to provide long-term relief and enhance quality of life, neurostimulation’s adoption is driving its remarkable growth in the U.S. pain management therapeutics market.

Neurostimulation has rapidly emerged as the fastest-growing segment in the U.S. pain management therapeutics market due to its non-invasive nature and effective relief for chronic pain. As patients seek alternatives to traditional medications, neurostimulation offers targeted pain modulation through implanted devices that deliver electrical impulses to the nervous system. This approach’s success in managing conditions like neuropathic pain, migraines, and spinal cord injuries has garnered significant interest among patients and healthcare professionals alike.

Devices – United States pain management therapeutics Market has been covered from 4 viewpoints.

1.    Electrical Stimulators

2.    Radiofrequency Ablation

3.    Analgesic Infusion Pumps

4.    Neurostimulation

Due to their proven efficacy and availability, opioids remain a significant component of the United States pain management therapeutics market.

Opioids hold the largest share in the market due to their potent analgesic properties, widespread use for acute and chronic pain, and historical prominence. While concerns about addiction and misuse persist, opioids remain a cornerstone of pain relief, especially for severe pain cases. Extensive patient need, healthcare provider familiarity, and regulatory frameworks contribute to their dominance.

Drug Class – United States pain management therapeutics Market has been covered from 7 viewpoints.

1.    Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)

2.    Anesthetics

3.    Anticonvulsants

4.    Anti-Migraine Agents

5.    Antidepressants

6.    Opioids

7.    Nonnarcotic Analgesics

Cancer pain is undergoing rapid expansion in the market due to the increasing prevalence of cancer and the need for effective pain relief.

 

With advancements in cancer treatment leading to prolonged survival, pain management has become paramount for maintaining patients’ quality of life. The development of specialized medications and interventions tailored to cancer-related pain, along with a growing emphasis on palliative care, has propelled the demand for targeted pain management solutions.

Indication – United States pain management therapeutics Market has been covered from 11 viewpoints.

1.    Arthritic Pai

2.    Neuropathic Pain

3.    Cancer Pain

4.    Chronic Back Pain

5.    Post-Operative Pain

6.    Migraine

7.    Fibromyalgia

8.    Bone Fracture

9.    Muscle Sprain/Strain

10.    Acute Appendicitis

11 .Others

Chronic pain commands the highest market share and represents the fastest-growing segment in the U.S. pain management therapeutics market.

Factors such as an aging population, rising prevalence of conditions like arthritis and back pain, and a heightened focus on improving patients’ overall well-being contribute to the growth. As research advances and treatment modalities evolve, pharmaceutical companies are innovating targeted solutions to address chronic pain, fostering its substantial market presence. The persistent need for effective long-term pain management positions chronic pain as a pivotal driver of growth in the U.S. pain management therapeutics market.

Pain Type – United States pain management therapeutics Market has been covered from 2 viewpoints.

1.    Chronic Pain

2.    Acute Pain

The online pharmacy sector continues to attract a widening customer base, propelling its remarkable growth within the market.

Due to the convenience and accessibility, it provides patients, the online pharmacy market has the highest market share and is the fastest-growing segment in the US pain management therapeutics industry. As digital healthcare gains traction, patients seek convenient prescription services, medication delivery, and information. The COVID-19 pandemic has accelerated this trend, leading to an increase in online purchases.

Distribution Channel – United States pain management therapeutics Market has been covered from 3 viewpoints.

1.    Hospital Pharmacies

2.    Retail Pharmacies

3.    Online Pharmacies

Competitive Landscape.

Pfizer Inc., GlaxoSmithKline plc, Novartis International AG, Merck & Co., Inc., Abbott Laboratories, Johnson & Johnson, and Baxter International Inc. are all major players in the United States pain management therapeutics industry.

Company Insights.

•    Overview

•    Recent Development

•    Financial Insight

Companies Covered.

1.    Eli Lilly and Company

2.    Pfizer Inc.

3.    GlaxoSmithKline plc

4.    Novartis International AG

5.    Merck & Co., Inc.

6.    Abbott Laboratories

7.    Johnson & Johnson

8.    Baxter International Inc.

About the Company: 

Renub Research is a Market Research and Information Analysis company with more than 14 years of experience in Research, Survey, and Consulting. Our research helps companies to take business decisions: on strategy, organization, operations, technology, mergers & acquisitions, etc. Till now we have published more than 7000 syndicated reports and worked on more than 500 custom research projects. Currently, we are supplying data to EMIS, Bloomberg, Thomson Reuters, etc. We support many blue-chip companies by providing them with findings and perspectives across a wide range of markets.

Media Contact:

Company Name: Renub Research

Contact Person: Rajat Gupta, Marketing Manager

Phone No: +1-478-202-3244 | +91-120-421-9822 (IND)

Address: 225 Kristie Ln, Roswell, GA 30076

Email: info@renub.com

LinkedIn: https://linkedin.com/company/renub-research

Thank You

Renub Research has recently released a report titled ” United States Pain Management Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2030,” providing a detailed industry analysis that includes market share insights. The report comprises competitor and regional research and contemporary United States Pain Management Therapeutics Market advancements. 

United States Pain Management Therapeutics Market will register a CAGR of 3.65% from 2022 to 2030

 Pain is a complex, unpleasant experience communicated to the brain through sensory neurons. It can be caused by actual or potential tissue damage and can last for a short duration (acute pain) or an extended period (chronic pain). Acute pain usually comes on suddenly and is caused by injury, while nerve damage, aged bone & joint conditions, or other underlying medical conditions can cause chronic pain. Pain management involves the use of medications and other therapeutic techniques to reduce or alleviate pain. It is a medical approach that combines science and alternative healing methods to study pain diagnosis, prevention, and treatment.

Chronic pain is a significant problem among older adults and has been linked to a multiplied danger of mortality. With the upward thrust of lifestyle diseases like diabetes and obesity, there was an increasing demand for nerve and muscle stimulators. With the upward push of life diseases like diabetes and weight problems, there was an increasing demand for nerve and muscle stimulators. The growing incidence of trauma or high blood stress is a substantial difficulty that is anticipated to propel a market upsurge. Hypertension expressively increases the danger of chronic conditions, which include thoughts mind aneurysms. According to the WHO, on March 2023, approximately 1.28 Billion adults aged 30 to 79 years globally are affected with hypertension. United States Pain Management Therapeutics Market is expected to reach US$ 33.71 Billion by 2030, driven by Growing incidences of chronic pain, Rising prevalence of sport injuries, Increasing number of surgical procedures and Huge base of elderly population

The development of the United States Pain Management market is predicted to be fueled with the aid of technological enhancements. For instance, WaveWriter Alpha Spinal Cord Stimulator Systems had been delivered inside the U.S. In January 2021. It was designed to relieve ache in few minutes without causing deep paresthesia. In February 2022, Boston Scientific Corporation received Baylis Medical Company Inc., which extended its product services in electrophysiology and structural coronary heart portfolios, which includes the VersaCross Transseptal and radiofrequency NRG Platforms and dilators used to access the left coronary heart. The Pain control market in the USA is predicted to be pushed by the growing extensive range of latest products released. Another crucial component is that Esteve Pharmaceuticals acquired FDA approval in October 2021 for SEGLENTIS, which is used to manage intense acute pain in adults that requires an opioid analgesic and has no other powerful remedies. The U.S. Pain control is predicted to enjoy good sized boom over the forecast period.

The pharmaceutical Pain Management Therapeutics Market within the United States is a dynamic and quickly evolving segment in the healthcare industry

The pharmaceutical Pain Management Therapeutics Market within the United States is evolving rapidly in the healthcare landscape. Marked by dynamic adjustments, this sector is adapting unexpectedly to emerging medical tendencies and patient needs. Continuous advancements in pain management cures and progressive pharmaceutical tactics contribute to the market speedy evolution. As the healthcare industry specializes in enhancing patient outcomes and addressing numerous pain associated challenges, the dynamic nature of the U.S. pain management therapeutics market reflects a dedication to staying at the forefront of scientific advancements and supplying effective solution for people grappling with pain issues. United States Pain Management Therapeutics Market is expected to reach US$ 33.71 Billion by 2030, driven by Growing incidences of chronic pain, Rising prevalence of sport injuries, Increasing number of surgical procedures and Huge base of elderly population

Therapeutics – United States Pain Management Therapeutics Market has been covered from 2 viewpoints:

1.    Pharmaceuticals

2.    Devices

Neurostimulation is quick gaining traction in the pain management drug market within the United States

Neurostimulation is rapidly gaining prominence in the pain management drug market in the United States. This revolutionary method makes use of advanced technologies to modulate the frightened devices, providing effective medication for individuals with chronic pain. The speedy traction of neurostimulation signifies a surge popularity of its efficacy as an opportunity or complementary solutions to standard pain management methods. As healthcare professionals and patients increasingly more embody this therapeutic avenue, neurostimulation is reshaping the landscape of pain control, imparting new opportunities for advanced patient outcomes and more desirable quality of lifestyles.

Devices – United States Pain Management Therapeutics Market has been covered from 4 viewpoints:

1.    Electrical Stimulators

2.    Radiofrequency Ablation

3.    Analgesic Infusion Pumps

4.    Neurostimulation

While opioids effectively relieve pain in the U.S., their growing use raises concerns about addiction and adverse effects.

In the United States, opioids serve as potent pain relievers, yet the increasing prevalence of their use sparks apprehension. The concern stems from the heightened risk of addiction and adverse effects associated with their widespread consumption. Despite their effectiveness in managing pain, the growing utilization of opioids underscores the urgent need for comprehensive strategies addressing addiction and mitigating potential harm. This dilemma prompts a reevaluation of pain management approaches, encouraging a shift towards alternative and safer solutions to strike a balance between pain relief and minimizing the risks posed by the escalating use of opioid medications.

Request a free sample copy of the report: https://www.renub.com/request-sample-page.php?gturl=united-states-pain-management-therapeutics-market-p.php

Drug Class – United States Pain Management Therapeutics Market has been covered from 7 viewpoints:

1.    Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)

2.    Anesthetics

3.    Anticonvulsants

4.    Anti-Migraine Agents

5.    Antidepressants

6.    Opioids

7.    Nonnarcotic Analgesics

Chronic ache captured the most significant market proportion and is the quickest growing within the U.S. pain management drug market.

In the U.S. Pain management therapeutics market, chronic pain dominates, with the most vital market proportion. This prevalence underscores the vast effect of persistent pain conditions and the growing demand for effective therapeutic interventions. As the healthcare landscape evolves, there is an exquisite emphasis on addressing the complexities of continual pain control. This segment’s massive market and speedy growth suggest the urgency to increase revolutionary pharmaceutical solutions and complete tactics tailored to alleviating the demanding situations associated with continual pain for stepped forward patient results.

Pain Type – United States Pain Management Therapeutics Market has been covered from 2 viewpoints:

1.    Chronic Pain

2.    Acute Pain

Indication – United States Pain Management Therapeutics Market has been covered from 11 viewpoints:

1.    Arthritic Pai

2.    Neuropathic Pain

3.    Cancer Pain

4.    Chronic Back Pain

5.    Post-Operative Pain

6.    Migraine

7.    Fibromyalgia

8.    Bone Fracture

9.    Muscle Sprain/Strain

10.    Acute Appendicitis

11.    Others

Given the convenience and accessibility of online platforms in the USA, more people choose online pharmacies to meet their medicinal drug necessities.

The USA witnessed a rising trend as individuals increasing choose online pharmacies for their medicinal drug requirements, driven by the convenience and accessibility presented by online platforms. This shift displays a converting consumer behavior, wherein the convenience of navigating digital platforms and acquiring medicinal drugs remotely will become a desired choice. Online pharmacies provide a convenient opportunity to standard brick-and-mortar pharmacies, catering to the evolving options of people in search of streamlined and available healthcare services. As technology keeps to shape healthcare reports, the recognition of online pharmacies in the USA underscores an extensive transformation in how human beings’ access and accumulate their essential medicines.

Distribution Channel – United States Pain Management Therapeutics Market has been covered from 3 viewpoints:

1.    Hospital Pharmacies

2.    Retail Pharmacies

3.    Online Pharmacies

Key Players

Eli Lilly and Company, Pfizer Inc., GlaxoSmithKline plc, Novartis International AG, Merck & Co., Inc., Abbott Laboratories, Johnson & Johnson, and Baxter International Inc. stand out as key players in the United States pain management industry.

Company Insights:

•    Overview

•    Recent Development

•    Financial Insight

Companies Covered:

1.    Eli Lilly and Company

2.    Pfizer Inc.

3.    GlaxoSmithKline plc

4.    Novartis International AG

5.    Merck & Co., Inc.

6.    Abbott Laboratories

7.    Johnson & Johnson

8.    Baxter International Inc.

About the Company: 

Renub Research is a Market Research and Information Analysis company with more than 15 years of experience in Research, Survey, and Consulting. Our research helps companies to take business decisions: on strategy, organization, operations, technology, mergers & acquisitions, etc. Till now we have published more than 7500 syndicated reports and worked on more than 650 custom research projects. Currently, we are supplying data to EMIS, Bloomberg, Thomson Reuters, etc. We support many blue-chip companies by providing them with findings and perspectives across a wide range of markets.

Media Contact:

Company Name: Renub Research

Contact Person: Rajat Gupta, Marketing Manager

Phone No: +1-478-202-3244 | +91-120-421-9822 (IND)

Address: 225 Kristie Ln, Roswell, GA 30076

Email: info@renub.com

LinkedIn: https://in.linkedin.com/company/renub-research

Web: www.renub.com